39
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Regulation of Cell Proliferation and Migration in Glioblastoma: New Therapeutic Approach

      research-article
      1
      Frontiers in Oncology
      Frontiers Media S.A.
      glioblastoma, cell migration and proliferation, miR-451, AMPK, cancer invasion and therapy

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Glioblastoma is the most aggressive brain cancer with the poor survival rate. A microRNA, miR-451, and its downstream molecules, CAB39/LKB1/STRAD/AMPK, are known to play a critical role in regulating a biochemical balance between rapid proliferation and invasion in the presence of metabolic stress in microenvironment. We develop a novel multi-scale mathematical model where cell migration and proliferation are controlled through a core intracellular control system (miR-451-AMPK complex) in response to glucose availability and physical constraints in the microenvironment. Tumor cells are modeled individually and proliferation and migration of those cells are regulated by the intracellular dynamics and reaction-diffusion equations of concentrations of glucose, chemoattractant, extracellular matrix, and MMPs. The model predicts that invasion patterns and rapid growth of tumor cells after conventional surgery depend on biophysical properties of cells, dynamics of the core control system, and microenvironment as well as glucose injection methods. We developed a new type of therapeutic approach: effective injection of chemoattractant to bring invasive cells back to the surgical site after initial surgery, followed by glucose injection at the same location. The model suggests that a good combination of chemoattractant and glucose injection at appropriate time frames may lead to an effective therapeutic strategy of eradicating tumor cells.

          Related collections

          Most cited references66

          • Record: found
          • Abstract: not found
          • Article: not found

          On the origin of cancer cells.

          O WARBURG (1956)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy.

            D Hardie (2007)
            The SNF1/AMP-activated protein kinase (AMPK) family maintains the balance between ATP production and consumption in all eukaryotic cells. The kinases are heterotrimers that comprise a catalytic subunit and regulatory subunits that sense cellular energy levels. When energy status is compromised, the system activates catabolic pathways and switches off protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. Surprisingly, recent results indicate that the AMPK system is also important in functions that go beyond the regulation of energy homeostasis, such as the maintenance of cell polarity in epithelial cells.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Cancer's molecular sweet tooth and the Warburg effect.

              More than 80 years ago, the renowned biochemist Otto Warburg described how cancer cells avidly consume glucose and produce lactic acid under aerobic conditions. Recent studies arguing that cancer cells benefit from this phenomenon, termed the Warburg effect, have renewed discussions about its exact role as cause, correlate, or facilitator of cancer. Molecular advances in this area may reveal tactics to exploit the cancer cell's "sweet tooth" for cancer therapy.
                Bookmark

                Author and article information

                Journal
                Front Oncol
                Front Oncol
                Front. Oncol.
                Frontiers in Oncology
                Frontiers Media S.A.
                2234-943X
                18 March 2013
                2013
                : 3
                : 53
                Affiliations
                [1] 1Department of Mathematics, Konkuk University Seoul, South Korea
                Author notes

                Edited by: Katarzyna A. Rejniak, H. Lee Moffitt Cancer Center and Research Institute, USA

                Reviewed by: Andrea Hawkins-Daarud, University of Washington, USA; Xuefeng Gao, Center of Cancer Systems Biology, USA

                *Correspondence: Yangjin Kim, Department of Mathematics, 120 Neungdong-ro, Gwangjin-gu, Seoul, 143-701, South Korea. e-mail: ahyouhappy@ 123456konkuk.ac.kr

                This article was submitted to Frontiers in Molecular and Cellular Oncology, a specialty of Frontiers in Oncology.

                Article
                10.3389/fonc.2013.00053
                3600576
                23508546
                ff5c0a4a-bc15-4733-96d4-33a6e766b366
                Copyright © 2013 Kim.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.

                History
                : 12 December 2012
                : 28 February 2013
                Page count
                Figures: 13, Tables: 2, Equations: 16, References: 84, Pages: 17, Words: 11653
                Categories
                Oncology
                Original Research

                Oncology & Radiotherapy
                ampk,cancer invasion and therapy,cell migration and proliferation,glioblastoma,mir-451

                Comments

                Comment on this article